Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2020 Third quarter results announcement
We announced our third quarter results for the period ended 30 September 2020 on Wednesday 28 October.
Latest information
Press releases for media
- GSK starts phase 3 study of RSV maternal candidate vaccine
- GSK and MMV present positive data on treatment for Plasmodium vivax malaria in children from 6 months up to 15 years of age
- ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention
- GSK presents Phase 2b data on linerixibat for the treatment of cholestatic pruritus in primary biliary cholangitis (PBC)
Sign up for announcements
Sign up to receive email notifications when we publish a stock exchange announcement.
Annual Report 2019
We published our Annual Report 2019 on 04 March 2020. View the summary and download the full report or individual sections.